GO:0070063 RNA polymerase binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070063 RNA polymerase binding is a molecular function defined as binding to an RNA polymerase molecule or complex.
• RNA polymerase binding underlies transcription initiation, promoter recognition, and enzyme regulation in prokaryotes and eukaryotes.
• Key proteins include RNA polymerase subunits, sigma factors, T7 RNA polymerase, and phage-encoded binding proteins.
• Structural studies show that RNA polymerase binding can be inhibited by antibiotics such as rifampicin.
• Binding affinity is influenced by DNA topology, promoter sequence, and supercoiling.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of RNA polymerase binding factors.
Description
RNA polymerase binding (GO:0070063) is a molecular function that describes the physical interaction between a protein or complex and an RNA polymerase molecule or complex. This binding event is fundamental to transcription, as it governs the recruitment, positioning, and activity of RNA polymerases at promoters and other regulatory regions. In prokaryotes, the earliest step of transcription is the specific binding of RNA polymerase to DNA, a process that requires accessory factors and is modulated by promoter architecture. In eukaryotes, RNA polymerase II transcription control depends on a vast array of binding proteins that regulate initiation and elongation. Understanding RNA polymerase binding is therefore central to deciphering gene expression, antibiotic mechanisms, and disease-associated transcriptional dysregulation. Researchers study this function using structural biology, biochemical binding assays, and genetic screens, with CRISPR-based models offering powerful tools to test causality.
RNA polymerase binding At A Glance
| GO ID | GO:0070063 |
|---|---|
| GO term | RNA polymerase binding |
| Ontology | molecular_function |
| Synonym | None |
| Definition | Binding to an RNA polymerase molecule or complex. |
| Major function | Mediates recruitment, regulation, and inhibition of RNA polymerases during transcription. |
| Related processes | Transcription initiation, promoter recognition, antibiotic response. |
| Example binders | Sigma factors, T7 RNA polymerase, phage proteins, rifampicin. |
What Is GO:0070063?
GO:0070063 RNA polymerase binding is defined by QuickGO as the binding to an RNA polymerase molecule or complex. This molecular function encompasses direct physical interactions between a binding partner (protein, nucleic acid, or small molecule) and any RNA polymerase, including bacterial RNA polymerase, bacteriophage RNA polymerases, and eukaryotic RNA polymerases I, II, and III. The term does not require catalytic activity; it specifically captures the binding event that may regulate polymerase recruitment, stability, or activity.
Why Is RNA polymerase binding Important in Cell Biology?
RNA polymerase binding is essential for all cellular life because it controls the first committed step of gene expression. In bacteria, the binding of RNA polymerase to promoters determines which genes are transcribed, and disruptions can lead to antibiotic resistance or virulence defects. In eukaryotes, RNA polymerase II binding proteins orchestrate complex transcriptional programs, and their dysfunction is linked to cancer and developmental disorders. Moreover, bacteriophage-encoded RNA polymerase binding proteins can hijack host transcription, offering insights into phage therapy and molecular evolution. Studying this function also informs drug discovery, as compounds like rifampicin specifically target RNA polymerase binding pockets.
• Controls transcription initiation and gene expression in all domains of life.
• Determines promoter specificity and response to environmental signals.
• Target of antibiotics such as rifampicin, which inhibits bacterial RNA polymerase binding.
• Mediated by sigma factors and phage proteins that modulate host transcription.
• Influenced by DNA supercoiling and template topology.
• Dysregulation is associated with cancer and transcriptional diseases.
• Provides a basis for CRISPR screens to identify novel binding regulators.
• Enables structural studies of polymerase complexes for drug design.
• Key to understanding bacteriophage-host interactions and phage therapy.
• Essential for synthetic biology and engineered transcription systems.
Molecular Mechanism of RNA polymerase binding
Promoter Recognition and Initial Binding
In simple terms: RNA polymerase must first find and attach to specific DNA sequences called promoters.
In prokaryotes, the earliest step of transcription is the specific binding of RNA polymerase to DNA at promoter regions. This binding is guided by sigma factors that recognize consensus sequences, and the stability of the closed complex depends on promoter strength and DNA topology. For T7 RNA polymerase, promoter binding is a highly specific process that can be modulated by template supercoiling.
Structural Basis of Binding and Inhibition
In simple terms: The shape of RNA polymerase determines how other molecules can attach to it.
Crystal structures of bacterial RNA polymerase have revealed the binding pocket for rifampicin, an antibiotic that blocks transcription by preventing the polymerase from forming a stable initiation complex. This structural mechanism highlights how small molecules can interfere with RNA polymerase binding and provides a template for drug design. Similarly, T7 RNA polymerase conformation and functional groups are critical for promoter binding.
Phage-Encoded Binding Proteins
In simple terms: Some viruses make proteins that grab onto the host RNA polymerase to control it.
Bacteriophage T5 encodes a novel RNA polymerase binding protein that interacts with the host enzyme, likely to redirect transcription toward phage genes. Another phage protein has been shown to bind at a sigma-factor docking site, mimicking or competing with host regulators. These examples illustrate the diversity of RNA polymerase binding strategies evolved by phages.
Eukaryotic RNA Polymerase II Binding and Regulation
In simple terms: In human cells, many proteins bind to RNA polymerase II to turn genes on or off.
RNA polymerase II transcription control involves a large set of binding proteins that regulate initiation, elongation, and termination. These factors recognize the polymerase complex and modulate its activity in response to cellular signals. Dysregulation of these binding events can lead to widespread changes in gene expression.
DNA Topology and Binding Affinity
In simple terms: The twisting of DNA affects how tightly RNA polymerase can hold on.
The binding affinity of T7 RNA polymerase to its promoter is higher on supercoiled DNA than on linearized templates, indicating that DNA topology plays a key role in polymerase binding. Similarly, rRNA gene promoters in Escherichia coli show specific binding characteristics that depend on sequence and supercoiling. These findings underscore the importance of template structure in RNA polymerase binding.
Key Genes Involved in GO:0070063 RNA polymerase binding
The following genes and proteins are directly implicated in RNA polymerase binding, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| rpoA | RNA polymerase subunit alpha | Core component of bacterial RNA polymerase; binding target for regulators |
| rpoB | RNA polymerase subunit beta | Rifampicin binding pocket; mutations confer antibiotic resistance |
| rpoC | RNA polymerase subunit beta' | Catalytic subunit; interacts with sigma factors |
| rpoD | Sigma factor 70 | Directs RNA polymerase to promoters; binding specificity |
| T7 gene 1 | T7 RNA polymerase | Model for promoter binding and conformational changes |
| T5.015 | Phage T5 RNA polymerase binding protein | Novel inhibitor of host transcription |
| gp33 | Phage T4 late transcription factor | Binds sigma-factor docking site |
| RPB1 | Eukaryotic RNA polymerase II largest subunit | Central to transcription control |
| RPB2 | Eukaryotic RNA polymerase II second largest subunit | Forms catalytic core; binding interface |
| TFIIB | General transcription factor | Binds RNA polymerase II to initiate transcription |
| TFIID | TATA-binding protein complex | Recognizes promoters and recruits polymerase |
| Mediator | Coactivator complex | Bridges transcription factors and RNA polymerase II |
| Rifampicin | Antibiotic | Binds bacterial RNA polymerase and inhibits transcription |
| Heparin | Polyanion | Used to study RNA polymerase binding in vitro |
| Supercoiled DNA | Template | Enhances T7 RNA polymerase binding affinity |
| rRNA promoter | DNA element | Specific binding site for E. coli RNA polymerase |
| Sigma factor | Transcription initiation factor | Directs polymerase to specific promoters |
How Is RNA polymerase binding Regulated?
RNA polymerase binding is regulated at multiple levels. In bacteria, sigma factors compete for binding to the core polymerase, and their availability changes in response to stress or growth phase. DNA supercoiling modulates binding affinity, as shown for T7 RNA polymerase and E. coli rRNA promoters. In eukaryotes, phosphorylation of the RNA polymerase II C-terminal domain and the action of Mediator complexes regulate the recruitment of binding partners. Phage-encoded proteins can also regulate host RNA polymerase binding by mimicking or blocking sigma factor interactions.
RNA polymerase binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| rpoB | Rifampicin resistance in tuberculosis | Point mutation knock-in in Mycobacterium smegmatis |
| rpoD | Bacterial stress response and virulence | Knockout in E. coli and infection models |
| RPB1 | Cancer transcriptional addiction | CRISPR knockout in cancer cell lines |
| T5.015 | Phage-host interaction | Overexpression in E. coli and phage infection assays |
| gp33 | Phage T4 late transcription | Knock-in of tagged version in phage genome |
Antibiotic Resistance and Bacterial Pathogenesis
Mutations in the rifampicin binding pocket of bacterial RNA polymerase (rpoB) confer resistance to rifampicin, a first-line antibiotic for tuberculosis. These mutations alter the binding affinity without abolishing transcription, highlighting the clinical importance of RNA polymerase binding. Understanding these binding interactions is critical for developing new antibiotics.
Cancer and Transcriptional Dysregulation
In eukaryotes, aberrant binding of coactivators and transcription factors to RNA polymerase II can drive oncogenic gene expression programs. Dysregulation of RNA polymerase II binding is observed in various cancers, making it a target for therapeutic intervention. Studying these interactions can reveal vulnerabilities in cancer cells.
Phage Therapy and Infectious Disease
Phage-encoded RNA polymerase binding proteins can shut down host transcription, contributing to phage virulence. Understanding these proteins may inform phage therapy strategies against antibiotic-resistant bacteria. They also serve as models for protein-protein interaction inhibitors.
From RNA polymerase binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene directly bind RNA polymerase? | Knockout + co-immunoprecipitation |
| Which residues mediate binding? | Point mutation knock-in |
| Can a phage protein inhibit host transcription? | Overexpression in E. coli |
| How does a disease mutation affect binding affinity? | Knock-in of patient variant |
| Where does binding occur in the cell? | Tagged knock-in + imaging |
| What genes regulate RNA polymerase binding? | CRISPR library screening |
How to Study the RNA polymerase binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| EMSA | Direct binding of protein to RNA polymerase or DNA | Validate candidate binders |
| SPR | Binding affinity and kinetics | Compare wild-type and mutant polymerases |
| X-ray crystallography | Atomic structure of binding interface | Drug design against RNA polymerase |
| CRISPR knockout screen | Genes required for RNA polymerase binding | Identify novel regulators |
| ChIP-seq | Genome-wide binding sites of RNA polymerase | Map transcription start sites |
| RNA-seq | Transcriptional changes upon binding perturbation | Assess functional impact |
| Co-immunoprecipitation | Protein-protein interactions | Confirm binding partners |
| Phage infection assay | Effect of binding proteins on host transcription | Study phage-host interactions |
Biochemical Binding Assays
Electrophoretic mobility shift assays (EMSAs) and surface plasmon resonance (SPR) are used to measure direct binding of proteins to RNA polymerase or promoter DNA. These methods quantify affinity and kinetics, as demonstrated for T7 RNA polymerase binding to supercoiled DNA.
Structural Biology
X-ray crystallography and cryo-EM reveal the atomic details of RNA polymerase binding interfaces, such as the rifampicin binding pocket. These structures guide mutagenesis and drug design.
Genetic Screens and CRISPR
CRISPR knockout and interference screens can identify genes that regulate RNA polymerase binding and transcription. Phage proteins discovered through such screens expand the repertoire of known binding factors.
Transcriptomics and Proteomics
RNA-seq and ChIP-seq measure the consequences of altered RNA polymerase binding on gene expression. Proteomics can identify novel binding partners through affinity purification.
How CRISPR Can Be Used to Study GO:0070063 RNA polymerase binding
Knockout
CRISPR knockout of genes encoding RNA polymerase subunits or binding factors can abolish transcription and reveal essentiality. For non-essential binders, knockout followed by RNA-seq identifies target genes.
Point Mutation
Point mutations in the rifampicin binding pocket of rpoB can be introduced to model antibiotic resistance and study binding affinity changes. Similarly, mutations in sigma factor docking sites can disrupt phage protein binding.
Knock-in
Knock-in of tagged RNA polymerase subunits enables imaging and proteomic analysis of binding complexes. Patient-derived mutations can be knocked into endogenous loci to study disease mechanisms.
Overexpression
Overexpression of phage-encoded RNA polymerase binding proteins can inhibit host transcription and serve as a model for phage therapy. Overexpression of eukaryotic transcription factors can drive oncogenic programs.
How EDITGENE Supports RNA polymerase binding Research
Researchers studying RNA polymerase binding-related genes often need to determine whether a candidate gene is causally involved in transcription regulation, antibiotic response, or disease. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for RNA polymerase binding research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PKN2 Knockout HEK293 Cell Line | EDJ-KQ848 | Human | 5586 | Details Get a Quote |
| ZFP36 Knockout HEK293 Cell Line | EDJ-KQ1014 | Human | 7538 | Details Get a Quote |
| CCNT1 Knockout HEK293 Cell Line | EDJ-KQ2254 | Human | 904 | Details Get a Quote |
| ERCC6 Knockout HEK293 Cell Line | EDJ-KQ2368 | Human | 2074 | Details Get a Quote |
| BIN1 Knockout HEK293 Cell Line | EDJ-KQ2419 | Human | 274 | Details Get a Quote |
| NEDD4 Knockout HEK293 Cell Line | EDJ-KQ2645 | Human | 4734 | Details Get a Quote |
| CCNT2 Knockout HEK293 Cell Line | EDJ-KQ3510 | Human | 905 | Details Get a Quote |
| PPIB Knockout HEK293 Cell Line | EDJ-KQ3788 | Human | 5479 | Details Get a Quote |
| STOM Knockout HEK293 Cell Line | EDJ-KQ4535 | Human | 2040 | Details Get a Quote |
| DHX57 Knockout HEK293 Cell Line | EDJ-KQ10680 | Human | 90957 | Details Get a Quote |
| TCERG1L Knockout HEK293 Cell Line | EDJ-KQ11836 | Human | 256536 | Details Get a Quote |
| PHRF1 Knockout HEK293 Cell Line | EDJ-KQ14749 | Human | 57661 | Details Get a Quote |
| YTHDC2 Knockout HEK293 Cell Line | EDJ-KQ16172 | Human | 64848 | Details Get a Quote |
| ZFP36 Knockout HCT 116 Cell Line | EDJ-KQ20083 | Human | 7538 | Details Get a Quote |
| ZFP36 Knockout HeLa Cell Line | EDJ-KQ20084 | Human | 7538 | Details Get a Quote |
- 1
- 2
- Next Page »
Frequently Asked Questions About RNA polymerase binding
What is RNA polymerase binding?
RNA polymerase binding (GO:0070063) is the molecular function of binding to an RNA polymerase molecule or complex, as defined by QuickGO.
What genes are involved in RNA polymerase binding?
Key genes include rpoA, rpoB, rpoC, rpoD, T7 gene 1, and phage proteins such as T5.015 and gp33.
How does rifampicin inhibit RNA polymerase?
Rifampicin binds to the bacterial RNA polymerase pocket and blocks the formation of a stable initiation complex, as shown by crystallography.
What is the role of sigma factors in RNA polymerase binding?
Sigma factors direct RNA polymerase to specific promoters, determining which genes are transcribed.
How is RNA polymerase binding studied?
Common methods include EMSA, SPR, X-ray crystallography, CRISPR screens, and ChIP-seq.
Does DNA supercoiling affect RNA polymerase binding?
Yes, supercoiled DNA enhances the binding affinity of T7 RNA polymerase compared to linearized templates.
What diseases are linked to RNA polymerase binding?
Mutations in rpoB cause rifampicin resistance, and dysregulated RNA polymerase II binding is implicated in cancer.
Can phages encode RNA polymerase binding proteins?
Yes, bacteriophage T5 and T4 encode proteins that bind host RNA polymerase to redirect transcription.
What CRISPR models are used to study RNA polymerase binding?
Knockout, point mutation knock-in, tagged knock-in, and overexpression models are widely used.
Why is RNA polymerase binding important for drug discovery?
It is the target of antibiotics like rifampicin, and understanding binding interfaces aids in designing new inhibitors.
Conclusion
RNA polymerase binding (GO:0070063) is a fundamental molecular function that governs transcription initiation and regulation across all domains of life. From bacterial sigma factors to phage-encoded inhibitors and eukaryotic coactivators, the proteins that bind RNA polymerase are critical for gene expression, antibiotic action, and disease. Continued research using structural biology, CRISPR screens, and biochemical assays will uncover new binding mechanisms and therapeutic opportunities.
References
- 1. Campbell EA et al.. 2001. Structural mechanism for rifampicin inhibition of bacterial rna polymerase.. Cell 104(6):901-12 PMID: 11290327
- 2. Klimuk E et al.. 2020. Novel Escherichia coli RNA Polymerase Binding Protein Encoded by Bacteriophage T5.. Viruses 12(8) PMID: 32722583
- 3. Wang Erickson AF et al.. 2017. A novel RNA polymerase-binding protein that interacts with a sigma-factor docking site.. Mol Microbiol 105(4):652-662 PMID: 28598017
- 4. Oakley JL et al.. 1975. T7 RNA polymerase: conformation, functional groups, and promotor binding.. Biochemistry 14(21):4684-91 PMID: 1101955
- 5. Slaska K. 1980. [Specific binding of RNA polymerase to DNA as the earliest step of transcription in Prokaryota (author's transl)].. Postepy Biochem 26(2):161-82 PMID: 6159616
- 6. Kiss I et al.. 1980. RNA-polymerase binding at the promoters of the rRNA genes of Escherichia coli.. Biochim Biophys Acta 609(3):435-47 PMID: 6159922
- 7. Kornberg RD. 1996. RNA polymerase II transcription control.. Trends Biochem Sci 21(9):325-6 PMID: 8870494
- 8. Chen YC et al.. 2000. Binding affinity of T7 RNA polymerase to its promoter in the supercoiled and linearized DNA templates.. Biosci Biotechnol Biochem 64(6):1126-32 PMID: 10923780
